|Appears in Collections:||Management, Work and Organisation Journal Articles|
|Peer Review Status:||Refereed|
|Title:||Research and development spending and technical efficiency: evidence from biotechnology and pharmaceutical sector|
Tzeremes, Nickolaos G.
data envelopment analysis
US biotechnology and pharmaceutical firms
|Citation:||Grant K, Matousek R, Meyer M & Tzeremes NG (2019) Research and development spending and technical efficiency: evidence from biotechnology and pharmaceutical sector. International Journal of Production Research p. 15. https://doi.org/10.1080/00207543.2019.1671623|
|Abstract:||Set within the expenditure context of the global financial crisis (GFC), this paper explores how the research and development (R&D) expenditures of biotechnology and pharmaceutical companies affect their technical efficiency levels. A balanced panel of 149 US firms operating in the biotechnology and pharmaceutical sector (covering the period 2000–2017) was employed. Output-oriented partial frontier measures were used to measure the effect of R&D expenditure on firms’ technical efficiency levels. Findings suggest that company efficiency is an important contributor on the effects of R&D on productivity and efficiency. Result suggests that a relationship between technical efficiency and R&D expenditure exhibits a ‘U’-shape relationship. The estimated efficiency of biotechnology firms is higher compared to pharmaceutical firms driven by their higher R&D expenditure levels. We demonstrate that R&D expenditures are essential for firm efficiency. We posit that a threshold level for achieving optimal efficiency levels exist, which can be used to inform managerial and policy-making decisions at the firm level.|
|Rights:||[Grant-etal_InJrnlProdResearch_v12_R_R1_Oct_2018.pdf] This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study. This is an Accepted Manuscript of an article published by Taylor & Francis Group in International Journal of Production Research on 30 Sep 2019, available online: http://www.tandfonline.com/10.1080/00207543.2019.1671623.|
[Research and development spending and technical efficiency evidence from biotechnology and pharmaceutical sector.pdf] The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.
|Notes:||Output Status: Forthcoming/Available Online|
|Research and development spending and technical efficiency evidence from biotechnology and pharmaceutical sector.pdf||Fulltext - Published Version||1.73 MB||Adobe PDF||Under Permanent Embargo Request a copy|
|Grant-etal_InJrnlProdResearch_v12_R_R1_Oct_2018.pdf||Fulltext - Accepted Version||1.02 MB||Adobe PDF||Under Embargo until 2020-10-01 Request a copy|
Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
If you believe that any material held in STORRE infringes copyright, please contact email@example.com providing details and we will remove the Work from public display in STORRE and investigate your claim.